Mirdametinib
CAS 391210-10-9Small Molecule
Overview
Mirdametinib is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL507361).
Patent & exclusivity (US)
Per the FDA Orange Book (3 approved US products), the latest listed US patent on Mirdametinib expires 10 Oct 2044 and exclusivity 11 Feb 2032. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide
- Canonical SMILES
- C1=CC(=C(C=C1I)F)NC2=C(C=CC(=C2F)F)C(=O)NOC[C@@H](CO)O
- InChIKey
- SUDAHWBOROXANE-SECBINFHSA-N
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.